Stock Report

Download full stock data and analysis for free Last Updated: 05-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

XTL Biopharmaceuticals - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$2.53

up-down-arrow $0.03 (1.20%)

As on 04-Sep-2026 13:21EDT

Market cap

info icon

$6 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1.9

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 0.00 -- -- -20.38 60.72
EBIT -- -254.52 -629.22 -2.27 -9.89
Net Profit 0.00 -152.58 -1,774.12 -212.96 10.67
EPS -200,389.27 -140.69 -1,447.00 -210.57 11.66
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-25Dec-24Dec-23
EBIT-Margin info -250.33-42.98---250.33--
Net Margin info ----------
Return on equity info -98.64-63.01-269.02-26.83-0.06
Return on Capital info -91.95-59.00-249.43-26.36-0.06
Return on Assets info -59.56-39.40-159.91-18.71-0.05
Debt to Equity (x) info -----1.060.03--

Profitability

View Detailed Peer Comparison

ROCE

-249.43

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
-249.43
-26.36
-0.06
-28.89
9.73
Peer Median
--
--
--
--
--
ROE

-269.02

--

Profit after tax / Average Net worth * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
-269.02
-26.83
-0.06
-28.89
9.73
Peer Median
--
--
--
--
--
ROA

-159.91

--

Profit after tax / Average Total assets * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
-159.91
-18.71
-0.05
-24.95
6.63
Peer Median
--
--
--
--
--
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
--
-250.33
--
191.72
-70.33
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
--
-227.72
--
293.68
29.67
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

-1.00

--

Year on year growth in net sales

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
-1.00
--
1.00
-1.31
51.36
Peer Median
--
--
--
--
--
EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
--
-47.58
13.07
14.65
-8.76
Peer Median
--
--
--
--
--
Net Profit Growth

-578.58

--

Year on year growth in profit after tax

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
-578.58
-57,531.87
99.87
-409.89
155.63
Peer Median
--
--
--
--
--
EPS Growth

-13,591.31

--

Year on year growth in earnings per share

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
-13,591.31
-2.56
1.00
-4.28
1.50
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

-1.06

--

Total debt / Net worth

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
-1.06
0.03
--
--
--
Peer Median
--
--
--
--
--
Short term debt to equity ratio

-1.06

--

(Short term borrowings / Net worth)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
-1.06
0.03
--
--
--
Peer Median
--
--
--
--
--
Current Ratio

0.40

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
0.40
0.61
9.93
20.35
27.00
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
--
--
10.07
--
--
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
--
-13.13
-191.30
-80.01
-49.10
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
--
21.95
--
-15.47
6.41
Peer Median
--
--
--
--
--
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
--
0.08
--
-0.08
0.22
Peer Median
--
--
--
--
--
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
--
51.83
--
-65.65
23.42
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
--
-23.64
--
--
--
Peer Median
--
--
--
--
--
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
--
80.31
--
730.50
730.50
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
--
-52.12
--
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

-0.04

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
-0.04
-1,738.57
-3,088.43
-0.31
2.29
Peer Median
--
--
--
--
--
Price / Book Value

-1.00

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
-1.00
328.52
2.48
0.10
0.19
Peer Median
--
--
--
--
--
EV/EBITDA

-0.51

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
XTL Biopharmaceuticals - ADR
-0.51
-1,918.82
-4.58
3.76
4.98
Peer Median
--
--
--
--
--
loading...
loading...